/wp-content/uploads/4dmt_logo.svg00Maria Gonzalez/wp-content/uploads/4dmt_logo.svgMaria Gonzalez2026-05-21 11:16:182026-05-21 11:21:57Development of a Novel Electro-Chemiluminescent Sandwich Immunoassay for the Detection of CFTR Specific Antibodies
/wp-content/uploads/4dmt_logo.svg00Maria Gonzalez/wp-content/uploads/4dmt_logo.svgMaria Gonzalez2026-05-21 11:06:532026-05-21 11:10:00Development of a Highly Sensitive Cell-based Infectivity Assay for the Assessment of AAV Vector Shedding in Clinical Serum Samples
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 11:00:212025-05-19 14:32:44Non-clinical Evaluation of 4D-310 in Combination With Rituximab/Sirolimus: A Translational Study to Support Adoption of a Novel Prophylactic Immunomodulation Regimen in Clinical Trials in Adults with Fabry Disease
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:57:142026-05-21 11:31:35Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up (Poster)
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:55:202025-05-19 14:35:48Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:52:532025-05-19 14:37:33Non-clinical Evaluation of 4D-310 in Combination With Rituximab/Sirolimus: A Translational Study to Support Adoption of a Novel Prophylactic Immunomodulation Regimen in Clinical Trials in Adults with Fabry Disease (Poster)
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-12-11 14:00:422024-12-11 14:14:40Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-09-17 17:06:282024-09-17 20:16:43Extended Follow-Up in the PRISM Clinical Trial Evaluating 4D-150 in Adults with Neovascular Age-related Macular Degeneration
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-07-15 08:40:252024-07-15 10:07:08Phase 2 Population Extension Cohort in the PRISM Trial Evaluating 4D-150 in Adults With Neovascular Age-related Macular Degeneration